Literature DB >> 25076014

Isolation of Rickettsia typhi from human, Mexico.

Jorge E Zavala-Castro, Karla R Dzul-Rosado, Gaspar Peniche-Lara, Raúl Tello-Martín, Jorge E Zavala-Velázquez.   

Abstract

Entities:  

Keywords:  Mexico; Rickettsia isolation; Rickettsia typhi; bacteria; centrifugation cell culture plate technique; human case

Mesh:

Year:  2014        PMID: 25076014      PMCID: PMC4111176          DOI: 10.3201/eid2008.130095

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Murine typhus is a febrile illness caused by Rickettsia typhi. The clinical manifestations are nonspecific, and the signs and symptoms resemble those of several other febrile illnesses. Murine typhus can be a self-limiting infection; however, it should be diagnosed and treated because complications and even death can result (). In Mexico, particularly in Yucatan State, cases of murine typhus in humans and high prevalence of antibodies in healthy blood donors have been reported (,). In 2012, we isolated R. typhi from a human patient in southeastern Mexico by using a simple and effective method, an adaptation of the centrifugation shell vial method to cell culture plates. The patient, a 23-year-old man from Dzibzantun (21°15′00″N, 89°03′00″W), in the northeastern part of Yucatan State, was referred for possible diagnosis of rickettsial infection. He had a low-grade fever (37.6°C) and a maculopapular rash on the thorax and upper and lower extremities. The patient reported having cats in the house, but no fleas or ticks were observed. Clinical laboratory findings were within reference ranges. Test results were negative for dengue virus, but the Weil-Felix (Proteus OX19) test result was positive (titer 1:164). Single-step PCR amplification was performed by using genus-specific primers for the 17-kDa lipoprotein and the citrate synthase gene (gltA), as described previously, to obtain amplicons of 434 bp and 380–385 bp (). PCR was positive for R. typhi, and 100 mg of oral doxycycline 2 times per day for 7 days was prescribed; the rash cleared. We subjected 5 mL of blood to centrifugation for 1 hour at 1,000 rpm and then stored the plasma at −80°C. Blood samples from other patients were used as controls. A total of 50,000 Vero cells were grown in 8 central wells of a 24-well cell culture cluster (Corning Incorporated, Corning, NY, USA) with minimal essential medium (MEM; Biowest, Nuaillé, France) supplemented with 10% fetal bovine serum (Biowest) and incubated at 37°C with 5% CO2 for 48 hours to obtain 95% confluence. We then thawed 700 μL of the plasma in a 37°C water bath. The MEM was discarded, and the wells were refilled with 250 μL each of a mixture of the plasma and fresh medium at a 1:3 ratio. The plaque was covered with parafilm and centrifuged at 700 g for 60 minutes at 22°C. The supernatant was discarded and replaced with 1 mL of MEM supplemented with 5% fetal bovine serum, 100 U penicillin, 100 μg streptomycin, and 250 ng amphotericin B (Sigma Aldrich, St. Louis, MO, USA) and incubated at 33°C with 5% CO2. On day 3 after sample inoculation, the antimicrobial drug–containing medium was removed and replaced with MEM without antimicrobial drug and supplemented with 5% fetal calf serum (HyClone Laboratories, Inc., South Logan, UT, USA). Medium was changed every 3 days until day 15. A cell sample from each well was tested for infection at days 9 and 15 by using Gimenez stain and PCR with 17 kDa and gltA primers. Gimenez staining on day 15 yielded numerous red-stained bacteria in the cytoplasm of Vero cells in the 8 wells used. A single scraping of the cells from the positive wells was inoculated onto confluent layers of Vero cells, which enabled establishment of the isolate. Three PCR amplicons of the 17kDa– and gltA–specific primers (–) from positive wells were fully sequenced. After removing primer sequences, we compared amplicon sequences by conducting a gapped BLAST 2.0 (http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi) search of the GenBank database; the 17-kDa (accession no. JX198507) and gltA (accession no. KC469611) gene fragment sequences showed 100% identity with R. typhi strain Wilmington (accession no. AE017197.1). Murine typhus has been reemerging in southeastern Mexico for the past 6 years (,). Active epidemiologic surveillance led to early detection of human cases and opportune treatment, thereby decreasing the rate of severe illness. However, the prevalent social and cultural conditions in small villages, with close contact with domestic, peridomestic, and wild animals, facilitate the transmission of this fleaborne rickettsiosis; human infections, such as the case presented here, still occur. We replaced shell vials with cell culture plates and isolated rickettsiae from a biological sample from a patient with acute murine typhus. The method is as simple as the shell vial centrifugation technique and is highly sensitive and easy to perform, making it an excellent choice for rickettsiae isolation when shell vials are not available. In the United States, isolation of R. typhi from a human was last reported >50 years ago (8). The case reported here reinforces the need to extend surveillance to small towns and villages in Yucatan State. It also shows that a shell vial alternative method for R. typhi isolation is simple and effective.
  8 in total

1.  Murine typhus in Mexico City.

Authors:  R Acuna-Soto; L Calderón-Romero; D Romero-López; A Bravo-Lindoro
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jan-Feb       Impact factor: 2.184

2.  Detection of murine typhus infection in fleas by using the polymerase chain reaction.

Authors:  L Webb; M Carl; D C Malloy; G A Dasch; A F Azad
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes.

Authors:  R L Regnery; C L Spruill; B D Plikaytis
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

4.  Plaque assay of rickettsiae.

Authors:  N Kordová
Journal:  Acta Virol       Date:  1966-05       Impact factor: 1.162

5.  Typhus and typhuslike rickettsiae associated with opossums and their fleas in Los Angeles County, California.

Authors:  S G Williams; J B Sacci; M E Schriefer; E M Andersen; K K Fujioka; F J Sorvillo; A R Barr; A F Azad
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Murine typhus in child, Yucatan, Mexico.

Authors:  Jorge E Zavala-Castro; Jorge E Zavala-Velázquez; Justo Eduardo Sulú Uicab
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

Review 7.  Louse- and flea-borne rickettsioses: biological and genomic analyses.

Authors:  Joseph J Gillespie; Nicole C Ammerman; Magda Beier-Sexton; Bruno S Sobral; Abdu F Azad
Journal:  Vet Res       Date:  2008-11-28       Impact factor: 3.683

8.  Murine typhus in humans, Yucatan, Mexico.

Authors:  Karla Dzul-Rosado; Pedro González-Martínez; Gaspar Peniche-Lara; Jorge Zavala-Velázquez; Jorge Zavala-Castro
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

  8 in total
  3 in total

1.  Direct evidence of Rickettsia typhi infection in Rhipicephalus sanguineus ticks and their canine hosts.

Authors:  Karla Dzul-Rosado; Cesar Lugo-Caballero; Raul Tello-Martin; Karina López-Avila; Jorge Zavala-Castro
Journal:  Open Vet J       Date:  2017-06-11

2.  Attitudes and Practices from People of a Mayan Community of Mexico, Related to Tick-Borne Diseases: Implications for the Design of Prevention Programs.

Authors:  Karla Dzul-Rosado; Cesar Lugo-Caballero; Juan Jose Arias-Leon; Freddy Pacheco-Tucuch; Gaspar Peniche-Lara; Jorge Zavala-Castro
Journal:  J Arthropod Borne Dis       Date:  2018-06-13       Impact factor: 1.198

3.  Murine typhus in Mexico City: report of an imported case.

Authors:  Sokani Sánchez-Montes; Pablo Colunga-Salas; Edith A Fernández-Figueroa; María Luisa Hernández Medel; César Rivera Benítez; Ingeborg Becker
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-03-11       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.